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Objective: Apoptosis and inflammation are important features of atherosclerotic plaques. We investigated whether a
common signal molecule can trigger these two apparently separate pathways. Hypoxia inducible factor (HIF-1) is
known to participate in atherosclerosis and to stimulate apoptosis signal-regulating kinase 1 (ASK-1), one of the
mitogen-activated protein kinases, which is activated by various extracellular stimuli and involved in a variety of cellular
function.
Methods: We tested carotid artery specimens from 50 subjects who underwent angioplasty and five age-matched controls
for either Western blot or histologic analysis. The hypoxic status was investigated by means of HIF-1 expression in
carotid specimens.
Results:HIF-1was significantly upregulated in carotid specimens with respect to controls (P< .05), ASK-1 was detected
in plaques of any composition from lipidic to calcific, and this expression increased with the stage of the plaque and with
the expression of inflammatory (p-ERK, RANK-L, OPG) and apoptotic molecules (caspase 9, p-p-38, and p-JNK).
Conclusion: Our data suggest that hypoxia is the key regulating factor that triggers inflammation as well as apoptosis in
the human atherosclerotic plaque. (J Vasc Surg 2010;52:1015-21.)
Clinical Relevance: This study adds evidence that HIF-1 is important in the oxidative stress response in the developing
atherosclerotic plaque as it modulates both inflammatory and mitochondrion-related apoptotic pathways. Future therapy
targeting HIF-1 may limit atherosclerosis development.A crucial moment in atherogenesis is thought to occur
when the remaining population of functional phagocytes
becomes unable to engulf all apoptotic remnants of dying
cells in the environment.1,2 Once the lesion contains a
large, necrotic, lipid pool that is covered by a fibrous cap,
primarily consisting of smooth muscle cells and extracellu-
lar matrix, it is named an atheroma.
In advanced atherosclerosis, death of macrophages in
the setting of defective phagocytic clearance of apoptotic
cells contributes to the development of plaque necrosis.
Plaque necrosis, in turn, is thought to promote plaque
disruption and arterial thrombosis, which are the proximate
causes of acute cardiovascular events.3,4
Apoptosis signal-regulating kinase-1 (ASK1), a mito-
gen activated protein kinase, has been initially identified as
a pro-apoptotic kinase. However, recently, ASK1 has been
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doi:10.1016/j.jvs.2010.05.116reported to also be implicated in a variety of cellular func-
tions, including cell proliferation, survival, differentiation,
and inflammatory response.5-7 Moreover, it has been pre-
viously reported that ASK1 is the critical signalling mole-
cule for angiotensin II-induced cardiac hypertrophy and
remodelling8 vascular neointimal thickening induced by
balloon injury9 and hind limb ischemia induced angiogen-
esis.10 Thus, ASK1 seems to be involved in a variety of
cardiovascular injuries. However, there is no report con-
cerning the role of ASK1 in human carotid plaques.
Various stimuli, such as TNF, Fas, and especially
oxidative stress, activate ASK1, which induces apoptosis or
stress responses through both JNK and p38 pathways acti-
vating the mitochondrial caspase-dependent apoptosis.11
Especially, the ASK1-Trx complex is thought to be a redox-
sensor, which functions as a molecular switch of external
and internal redox status for the kinase signaling module.
Multiple death signals are integrated into ASK1. In turn,
the signals are transduced to mitochondria and nucleus,
through the ASK1-JNK/p38 pathway. The balance be-
tween cellular life and death may be determined by timing,
duration, extent, and pattern of the ASK1-mediated JNK
and p38 activations, to make appropriate responses to
various types of extracellular and intracellular stress.12 Ap-
optosis in atherosclerotic plaques can be activated by either
oxidative stress that causes hypoxia or shear stress that
causes a persistent inflammatory status.
It has been recently shown that the late stage of the
atherosclerotic plaque calcification is affected by the bal-
ance between osteoprotegerin (OPG) and receptor activa-
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known actors in bone metabolism but have been recently
indicated as determinants of plaque calcification as well.13
Moreover, RANK-L can be stimulated by inflammatory
cytokines such as IL-1 and TNF-.14
In light of these observations, the aim of our study was
to investigate in human carotid plaques specimens, the
expression of somemarkers of hypoxia and inflammation to
better understand if a common pathway can be identified
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plied with the Declaration of Helsinki. Fifty consecutive
patients were enrolled and signed an informed consent
form before surgery. Patients have been selected based on
plaque composition as determined by duplex ultrasound,
y. Arrow head indicates an early fatty streak. B, H&E
ue, while connective tissue stains pink. The rectangle
2. C, H&E staining, detail showing a normal arterial
rome staining, collagen fibers stain green, while muscle
r indicates collagen tissue. Original magnification20.
tid artery. F, H&E staining. The rectangle represents the
hrome staining. The rectangle represents the area studied
showing an altered morphological architecture with
deposition. Original magnification 20. I, Masson’s
green color indicates fibrose tissue. Original magnifi-arter
in bl
cation
trich
n colo
caro
’s tric
detail
issue
andto obtain an equal number of subjects for each plaque type
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 4 Bitto et al 1017(n  10 for each type). Principal risk factors were hyper-
tension (90%), diabetes (36%), dyslipidemia (48%), and
smoking habit (34%). Mean age was 74 years.
Five control carotid arteries were removed at autopsy
from age-matched car crash victims with the consent of a
legal representative. Before the operation, all patients un-
derwent duplex ultrasound to determine the extent of the
atherosclerotic plaque as well as the composition of the
plaque that was further confirmed by a pathologist. Indica-
tion for surgery in asymptomatic patients (40%) was a
carotid stenosis of about 80%, according to the results of
Asymptomatic Carotid Atherosclerosis Study (ACAS) tri-
al;15 in symptomatic patients (60%) indication for surgery
was according to the results of North American Symptom-
atic Carotid Endarterectomy Trial (NASCET)16 and Euro-
pean Carotid Surgery Trial (ECST)17 studies.
The patient was placed in a supine position and a 7-10 cm
incision was made along the anterior border of the sternoclei-
domastoid. After clamping, the internal carotid artery (ICA)
was transected obliquely proximal to the bulb and a full
thickness circumferential mobilization of the ICA was per-
Fig 2. A, Representative Western blot of p-eNOS in car
the other groups n  10. *P  .05 vs controls. B, Rep
represents mean SD. Controls n 5. All the other gro
blot of p-ERK in carotid arteries. Bars represents mean 
vs controls. D, Representative Western blot of p-ASK-1
5. All the other groups n10. *P  .05 vs controls.formed close to the distal clamp. Near the end point, theplaque was pinched and removed from the vessel for a total
extension of 2-2.5 cm. The plaque on the external carotid
artery (ECA) was removed by traction and partial eversion
1-1.5 cm from the origin of the ECA itself. The plaque on the
common carotid artery (CCA) was extracted by eversion and
transection of the plaque flushwith the everted edge 1-1.5 cm
from the bifurcation along the CCA.
Histology. Analysis was performed by a blinded inves-
tigator. Formicroscopic histologic evaluation, carotid spec-
imens were removed and immediately fixed in 10% neutral
buffered formalin. The specimens were placed in decalcify-
ing solution (8% of chloridric acid 37% and 10% of formic
acid 89% in PBS) at 37°C, dehydrated in graded ethanol,
and then embedded in paraffin. Three 5-m-thick paraffin-
embedded sections were cut, dyed with a hematoxylin-
eosin or Masson’s Trichrome stain and studied using light
microscopy.
Immunohistochemistry. Paraffin-processed sections
were deparaffinized and rehydrated in graded ethanol solu-
tions. Slides were then rinsed in distilled water and treated
with 3% hydrogen peroxide in methanol (10 minutes at
arteries. Bars represents mean SD. Controls n 5. All
tative Western blot of p-eNOS in carotid arteries. Bars
 10. *P .05 vs controls. C, Representative Western
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before blocking with goat antiserum (30 minutes at room
temperature). Primary antibodies HIF-1 (Chemicon, Te-
mecula, Calif) and anti-pJNK (Cell Signaling, Beverly,
Mass) were then added and sections were incubated over-
night at 4°C. After rinsing in PBS, standard Vectastain
(ABC) avidin-biotin peroxidase complex (Vector Labora-
tories, Burlingame, Calif) was applied, and the slides were
incubated at room temperature for a further 30 minutes.
Color was developed using diaminobenzidine and sections
were dehydrated, cleared, and mounted. Specificity of the
immunoreaction was confirmed by a lack of immunostain-
ing in control sections, in which the primary antibody was
replaced with either PBS or pre-immune serum, and the
secondary antibody was replaced by an irrelevant antibody
or PBS (data not shown).
Western blot analysis. Samples from carotid plaques
were homogenized in lysis buffer (1% Triton; 20 mM
Tris/HCl, pH 8.0; 137 mM NaCl; 10% glycerol; 5 mM
EDTA; 1mMphenylmethylsulfonyl fluoride; 1% aprotinin;
15 g/mL leupeptin). Protein samples (30 g) were de-
natured in reducing buffer (62 mmol Tris/HCl, pH 6.8,
10% glycerol; 2% SDS; 5% -mercaptoethanol; 0.003%
bromophenol blue) and separated by electrophoresis on a
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Fig 3. A, HIF-1 immunostaining in fibrocalcific car
magnification 40. P  .01 vs controls. B, p-JNK imm
diffuse cytoplasmic reactivity. Original magnification 
HIF-1 in carotid arteries. Bars represent mean  SD.
controls. D, Representative Western blot of p-JNK in car
the other groups n  10. *P  .05 vs controls.SDS (12%) polyacrylamide gel. The separated proteins weretransferred on to a nitrocellulose membrane using the
transfer buffer (39 mM glycine, 48 mM Tris/HCl pH 8.3,
20%methanol) at 200mA for 1 hour. Themembranes were
stained with Ponceau S (0.005% in 1% acetic acid) to
confirm equal amounts of protein and blocked with 5%
non-fat dry milk in TBS-0.1% Tween for 1 hour at room
temperature, washed three times for 10 minutes each in
TBS-0.1% Tween, and incubated with a primary antibody
for HIF-1, phospho-ASK-1, active caspase-9, RANK-L
and OPG (Chemicon); phospho-p-38, phospho-JNK and
phospho-e-NOS (Cell Signaling); and i-NOS (Abcam,
Cambridge, UK) in TBS-0.1% Tween overnight at 4oC.
After being washed three times for 10 min each in TBS-
0.1% Tween, the membranes were incubated with a specific
peroxidase-conjugated secondary antibody (Pierce, Rock-
ford, Ill) for 1 h at room temperature. After washing, the
membranes were analyzed by the enhanced chemilumines-
cence system according to the manufacturer’s protocol
(Amersham, Little Chalfont, UK). The protein signal was
quantified by scanning densitometry using a bio-image
analysis system (Bio-Profil Celbio,Milan, Italy). The results
were expressed as relative integrated intensity compared
with controls and subtracting respective backgrounds.
More in detail the background is represented by -actin
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stripped blots by immunodetection of -actin with a rabbit
monoclonal antibody (Cell Signaling) and peroxidase-con-
jugated goat anti-rabbit immunoglobulin G (Pierce). An-
tibodies were purified by protein A and peptide affinity
chromatography. All experiments were repeated at least
twice, and a representative example is shown.
Statistical analysis. All data are expressed as means
standard deviation (SD). The significance of difference was
assessed by a two-way repeated measures analysis of vari-
ance (ANOVA) followed by post hoc analyses. In all cases,
a probability error of less than .05 was selected as the
criterion for statistical significance. Graphs were performed
using GraphPad Prism (version 4.0 for Windows).
RESULTS
Histologic classification of plaques. Histology con-
firmed plaque composition as determined by ultrasound in
all cases. Furthermore, it was possible to subdivide plaques
according to the main representative features into five
phenotypes: lipidic (foam cells with lymphocytes), fibroli-
pidic (a relatively acellular, loose arrangement of collagen
Fig 4. A, Representative Western blot of p-p38 in carot
other groups n  10. *P  .05 vs controls. B, Represent
represent mean  SD. Controls n  5. All the other gro
blot of OPG in carotid arteries. Bars represents mean S
controls. D, Representative Western blot of RANKL in c
the other groups n  10. *P  .05 vs controls.fibers), fibrotic (acellular area of dense collagen fibers),fibrocalcific (dense collagen fibers with calcific deposits),
and calcific (heavily calcified tissue with or without spots of
necrosis).
Carotid segments from control subjects showed only
an early fatty streak that can be considered more than
normal considering the age of the subjects (Table). Fig 1,A
through D, represents a carotid artery from a control sub-
ject with an initial fatty streak and a conserved intima and
media layers where collagen and muscular fibers are well
visible. Fig 1, E through I , is a representative fibrocalcific
plaque with initial ulceration in the core and loss of normal
architecture.
Hypoxia induces inflammatory response in plaques.
All the plaque phenotypes showed a hypoxic state as indi-
cated by the progressive decrease in p-eNOS (Fig 2, B;
control 8 0.8 integrated intensity, calcific 2.8 0.5
integrated intensity; P .05) and the increase in iNOS (Fig
2, C; control  1.5  0.3 integrated intensity, calcific 
6.5  1.1 integrated intensity; P  .05) expression in
plaques, with respect to normal carotids. Because of the
enhanced oxidative stress, a significant staining of nuclear
HIF-1 has been found in plaques (Fig 3, A, P  .01 vs
eries. Bars represent mean SD. Controls n 5. All the
Western blot of active caspase-9 in carotid arteries. Bars
 10. *P  .05 vs controls. C, Representative Western
ontrols n 5. All the other groups n 10. *P .05 vs
arteries. Bars represent mean SD. Controls n 5. Allid art
ative
ups n
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Western blot (Fig 2, D; P  .05 vs controls).
Hypoxia induces apoptosis in plaques via ASK-1,
JNK, p-38, and caspase-9. HIF-1 staining in athero-
sclerotic plaques was associated with p-JNK increase at the
same site that was more prominent in fibrocalcific plaques
(Fig 3, B; P  .01 vs controls), as well as an increase in
p-ASK-1 (Fig 2, E; P  .05 vs controls), p-JNK (Fig 3, D;
P .05 vs controls), p-p38 (Fig 4,A; P .05 vs controls),
and active caspase-9 (P  .05 vs controls) as detected by
Western blot (Fig 4, B).
Hypoxia triggers calcification markers expression.
The end stage of atherosclerotic plaques is calcification,
thus, we also investigated whether this process could be
activated in earlier stages by the Western blot expression of
OPG and RANKL. Interestingly, OPG was upregulated in
plaques roughly in the same extent (P  .05 vs controls)
with a peak of expression in calficic specimens (Fig 4,C). In
the same way, a progressive decrease in RANKL expression
has been observed in all specimens with respect to controls
(P  .05 for fibrotic, fibrocalcific, and calcific plaques; Fig
4, D).
DISCUSSION
The onset of plaque formation is characterised by cir-
culating levels of oxidized low-density lipoproteins, which
are capable of penetrating the endothelial border while
inflicting oxidative damage on the endothelial cells in the
process. Subsequently, the reactionary expression of in-
flammatory markers on the endothelial cell surface attracts
circulating monocytes, which differentiate into macro-
phages and start ingesting the available lipid and other
oxidized particles. Uninhibited intracellular lipid accumu-
lation compromises the function of macrophages and con-
verts them into foam cells.1 At a certain point, excess
damage to macrophages and smooth muscle cells induces
apoptosis, causing remnants of lipid-laden dead cells to
form small extracellular lipid droplets.
The main findings of our study are the early expression
of apoptotic molecules in the atherosclerotic plaque and
the involvement of oxidative stress in triggering an inflam-
matory as well as an apoptotic response. These cascades
might be linked through the activation of either HIF-1
and/or ASK-1 pathways (Fig 5); however, this hypothesis
needs to be proved in further studies. It has already been
shown that hypoxia and its related factor HIF-1 are
present in athermatous plaques and this latter is correlated
with plaque progression. HIF-1 also regulates NOS ex-
pression in plaques at different stages and eventually intra-
plaque angiogenesis18 via the expression of VEGF genes by
binding to the hypoxia response element in the VEGF
promoter region. In the presence of oxygen, HIF-1 pro-
tein is rapidly degraded via ubiquitination and subsequent
degradation by proteasome. Under hypoxia, HIF-1 is not
hydroxylated and therefore cannot be degraded. Conse-
quently, HIF-1 accumulates in the nucleus, forms an
active complex with HIF-1, and activates transcription of
target genes. Furthermore, other authors correlatedHIF-1 with the proinflammatory status of atherosclerotic
plaques.19 This supports our immunostaining results show-
ing HIF-1 localization in either perivascular tissue or
inflammatory macrophages. In addition, HIF-1 can stim-
ulate the expression of ASK-1 leading to the activation
of the mitochondrial apoptosis signalling pathway. We
showed that HIF-1 expression correlates with NO prod-
ucts and iNOS expression, although it also triggers ASK-1
expression and caspase-9 activation through the JNK path-
way. Caspase-9 is one of the initiator caspases responsible
for mitocondrial apoptosis and has been already observed in
macrophages surrounding the unstable plaque. The au-
thors suggest this molecule to be a key determinant in
plaque ulceration and rupture.20 The authors also showed
an increase in pro-apoptotic MAPKs as p38 and JNK.
Indeed, we found the same increase in these molecules but
we further showed an augmented expression of ASK-1,
which is the leading activator of this pathway. The slight
decrease inMAPKs activation observed in calcific plaques is
consistent with a decrease of macrophages in these lesions
due to calcification itself. All these are early events and are
strictly connected in plaque development and further in-
creased with plaque evolution as demonstrated. In addi-
tion, our data showing the activation of the mithocondrial
apoptotic pathway, further confirm the findings of Sarai
and coworkers in experimental animals treated with inhib-
itors of caspases belonging to both pathways.11 In addition,
it could be speculated that the rise in oxidative stress
highlighted by the decreased eNOS expression and the
consequent increase in iNOS might account for the activa-
tion of HIF-1 and for a proinflammatory status character-
ized by augmented ERK expression in the plaque. As we
hypothesize, the common initiator is oxidative stress, which
through HIF-1 in turn activates inflammation and apo-
ptosis from the very early moments of plaque formation.
Fig 5. Proposed cascade of events triggered by oxidative stress in
atherosclerotic plaque.Indeed, we also found that other molecules related to the
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Volume 52, Number 4 Bitto et al 1021final stages of atheromasia, as RANK-L and its decoy recep-
tor OPG, are expressed early. Indeed, p-ERK can upregu-
late RANK,21 and this might in turn lead to a decrease in
RANK-L and a consequent increase in OPG, as we have
demonstrated. OPG expression suggests that, potentially,
all plaques can go through the same cascade of events that
lead to calcification and stabilization instead of ulceration
and rupture. On the other hand, RANK-L and OPG serum
levels have been proposed as biomarkers of vascular risk and
prognosis correlating with the narrowing of the arterial
wall22 as well as with the severity of coronary artery dis-
ease.23 It has been reported that these levels are elevated in
myocardial infarction subjects,24 suggesting that calcifica-
tion is crucial for plaque destabilization and rupture.25
However, whether the imbalance in OPG/RANK-L ratio
is a consequence or a causal factor of plaque destabilization
still deserves further investigation. Obviously, genetic back-
ground as well as medical therapy and lifestyle are respon-
sible for a different story in plaque evolution. It becomes
more evident that future therapies should be addressed to a
modulation of HIF-1, since it seems to be responsible for
triggering both inflammatory and mitochondrion-related
apoptotic pathways.
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